Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified

Breast Cancer Research and Treatment

Volumn 43, Issue 1, 1997, Pages 43-51

  Lazaris, Andreas Ch ^a,c   Chatzigianni, Emmy B ^b   Panoussopoulos, Dimitris ^b   Tzimas, George N ^b   Davaris, Panayotis S ^a   Golematis, Basil Ch ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KAT HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Breast cancer; HSP70; Immunohistochemistry; PCNA; Prognosis

Indexed keywords

CYCLINE; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN 70; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CELL; CANCER SURVIVAL; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0031040584     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005706110275     Document Type: Article

References (38)

1. Schwartz GF, Schwarting R, Rabindranauth P, Finkel GC: Clinical applications of serum and tissue markers in malignant disease: breast cancer as the paradigm. Clin Chem 39 (11Pt2): 2404-2412, 1993
2. Marshall E: Search for a killer. Locus shifts from fats to hormones. Science 259: 618-623, 1993
3. O'Higgins N: Aspects of breast cancers. Chirurgie 118(5): 324-327, 1992
4. Hall PA, Levison DA, Woods AL: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections as index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162(4): 285-294, 1990
5. Benz CC, Keniry MA, Lord JM: Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers. Mol Pharmacol 37(6): 840-847, 1990
6. Mivechi NF, Rossi JJ: Use of polymerase chain reaction to detect the expression of the MR 70,000 heat shock genes in control or heat shock leukemic cells as correlated to their heat response. Cancer Res 50(10): 2877-2884, 1990
7. Robbins SL: Pathologic Basis of Disease, 5th Ed. W.B. Saunders, Philadelphia, 1994, pp 291-303
8. Porter-Jordan K, Lippman ME: Overview of the biologic markers of breast cancer. Hematol Oncol Clin North Am 8(1): 73-100, 1994
9. Ciocca DR, Fuqua SA, Lock-Lim S: Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 52: 3648-3654, 1992
10. Miller WR, Ellis IO, Sainsbury JRC, Dixon JM: ABC of breast diseases: Prognostic factors. BMJ 309: 1573-1576, 1994
11. Pelosi G, Bresaola E, Menacherry MJ, Manfrin E, Iannuci A: Methodological aspects of the immunostaining of proliferating cell nuclear antigen (PCNA) in cytospin preparations of MCF-7 cell line. Diagn Cytopathol 10(1): 82-85, 1994
12. Haerslev T, Jacobsen GK: Microwave processing for immunohistochemical demonstration of proliferating cell nuclear antigen (PCNA) in formalin-fixed and paraffin-embedded tissue. APMIS 102(5): 395-400, 1994
13. Lazaris ACh, Davaris P, Nakopoulou L, Theodoropoulos GE, Koullias G, Golematis BCh: Correlation between immunohistochemical expression of proliferating cell nuclear antigen and flow cytometry parameters in colorectal neoplasia. Dis Colon Rectum 37(11): 1083-1089, 1994
14. Oda Y, Hashimoto H, Takeshita S, Tsuneyoshi M: The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Cancer 72(2): 478-484, 1993
15. Frierson HF Jr: Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables. Mod Pathol 6(3): 290-294, 1993
16. Betta PG, Battero G, Pavesi M, Pastormelo M, Bellinger D, Tallarida F: Cell proliferation in breast carcinoma assessed by a PCNA grading system and its relation to other prognostic variables. Surg Oncol 2(1): 59-63, 1993
17. Cummings MC, Jurnival CM, Parsons PG, Townsend E: PCNA immuno-staining in breast cancer. Aust N Z J Surg 63(8): 630-636, 1993
18. Aaltomaa S, Lipponen P, Syrjanen K: Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer. Anticancer Res 13(2): 533-538, 1993
19. Siitonen SM, Isola JJ, Rantala IS, Helin HJ: Intratumor variation in cell proliferation in breast carcinoma as determined by antiproliferating cell nuclear antigen monoclonal antibody and automated image analysis. Am J Clin Pathol 99(3): 226-231, 1993
20. Aaltomaa S, Lipponen P, Papinaho S, Syrjanen K: Proliferating cell nuclear antigen (PC10) immunolabeling and other proliferation indices as prognostic factors in breast cancer. J Cancer Res Clin Oncol 119(5): 288-294, 1993
21. Schimmelpenning H, Eriksson ET, Franzen B, Zetterberg A, Auer GU: Prognostic value of the combined assessment of proliferating cell nuclear antigen immunostaining and nuclear DNA content in invasive mammary carcinomas. Virchows Arch A Pathol Anat Histopathol 423(4): 273-279, 1993
22. Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB: Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst 85(9): 727-731, 1993
23. Tuccari G, Kizzo A, Muscara M, Giuffre G, Barresi G: PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinicopathologic aspects. Pathologica 85: 47-55, 1993
24. Botti G, Chiappetta G, D'Aiuto G et al.: PCNA/cyclin and P-glycoprotein as prognostic factors in locally advanced breast cancer. An immunohistochemical retrospective study. Tumori 79(3): 214-218, 1993
25. 1 breast cancer. Gan To Kagaku Ryoho 20(6): 821-823, 1993
26. Gasparini G, Meli S, Pozza F, Cazzavillan S, Bevilacqua P: PC-10 antigen to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinoma. Growth Regul 2(4): 145-150, 1992
27. Horigushi J, Iino Y, Takei H, Morishita Y, Nakajima T: Expression of proliferating cell nuclear antigen in invasive ductal carcinoma of the breast. Jpn J Clin Oncol 24(2): 79-84, 1994
28. Jaatela M, Wissing D: Heat shock proteins product cells from monocyte cytotoxicity: possible mechanism of self protection. J Exp Med 177(1): 231-236, 1993
29. Jaatela M: Overexpression of major heat shock protein HSP70 inhibits tumor necrosis factor induced activation of phospholipase A2. J Immunol 151(8): 4286-4294, 1993
30. Srivatsava PK, Udono H, Blachere NE, Li Z: Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39(2): 93-98, 1994
31. Ciocca DR, Clark GM, Tandon AK, Fuqua SAW, Welch WJ, McGuire WL: Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: Prognostic implications. J Natl Cancer Inst 85(7): 570-574, 1993
32. Koskinen PJ, Sistonen L, Evan G: Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc overexpressing cells. J Virol 65: 842-851, 1991
33. Lehmann TA, Bennett WP, Metcalf RA: P53 mutations, ras mutations and p53-heat shock protein complexes in human lung carcinoma cell lines. Cancer Res 51: 4090-4096, 1991
34. Davidoff AM, Iglehart DI, Marks JR: Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancer. Proc Natl Acad Sci 89: 3439-3442, 1992
35. Van Buskirk AM, De Nagel DC, Guagliardi LE: Cellular and subcellular distribution of PBP 72/74, a peptide-binding protein that plays a role in antigen processing. J Immunol 146(2): 500-506, 1991
36. Yougel RA, Elliot TJ: Stress proteins, infection and immune surveillance. Cell 59: 5-8, 1989
37. Kost SL, Smith DF, Sullivan WP: Binding of heat shock proteins to the avian progesterone receptor. Mol Cell Biol 9: 3829-3838, 1989
38. Edwards DP, Estes PA, Fadok VA: Heat shock alters the composition of heteromeric steroid receptor complexes and enhances receptor activity in vivo. Biochemistry 31(9): 2482-2491, 1992